MDSpire - Summary
Feature

Recipients Named for the 2026 Pezcoller Foundation–AACR International Award

The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will be presented to Douglas R. Lowy, MD, and John T. Schi...

Share

Dr. Douglas R. Lowy and Dr. John T. Schiller will receive the Pezcoller Foundation–AACR International Award for extraordinary achievements in cancer research at the AACR Annual Meeting 2026 in San Diego. They are recognized for their pioneering work in developing the HPV vaccine, which protects against cervical and several other cancers caused by the virus. Their contributions include demonstrating the vaccine's safety, efficacy, and the pivotal role of HPV vaccination in reducing cancer incidence globally. Their efforts align with WHO recommendations for single-dose vaccination to enhance global uptake.

Original Source(s)

Recipients Named for the 2026 Pezcoller Foundation–AACR International Award

  • by The ASCO Post Staff

  • March 27, 2026

Related Content

Industry Insights: Genomic Testing for Early-Stage Breast Cancer

William Audeh, Chief Medical Officer at Agendia, discusses recent data supporting genomic testing results in guiding clinical decision-making

  • March 27, 2026

  • 8 min
AI As Collaborator in Cancer Research and in Clinical Care

Last October, the Cancer AI Alliance (CAIA) announced the launch of its collaborative artificial intelligence (AI) platform powered by federated learning to train AI models with millions of de-identif...

AI Use in Cancer Diagnosis, Prognosis, and Treatment: Are We There Yet?

The promise of artificial intelligence (AI) technologies to provide highly personalized oncology care for patients and improve outcomes has been decades in the making. In a 1987 editorial in The New E...